|
"tsou hsiao hui"的相关文件
显示项目 1-10 / 22 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-09-21T23:32:22Z |
Validation of clinical frailty scale in Chinese translation
|
YI-CHUN CHOU; Tsou, Hsiao Hui; DING-CHENG CHAN; Wen, Chiung Jung; FENG-PING LU; Lin, Kun Pei; Wu, Meng Chen; YUNG-MING CHEN; Chen, Jen Hau |
| 臺大學術典藏 |
2021-02-03T08:17:44Z |
Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version
|
Chan, Ding-Cheng Derrick; Tsou, Hsiao-Hui; CHIN-YING CHEN; Chen, Ching-Yu |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 國立臺北護理健康大學 |
2017-02 |
Integrated care for geriatric frailty and sarcopenia: a randomized control trial
|
Chan, Ding-Cheng Derrick; Tsou, Hsiao-Hui; Chang, Chirn-Bin; Yang, Rong-Sen; Tsauo, Jau-Yih; Chen, Ching-Yu; Hsiao, Chin-Fu; Hsu, Ya-Ting; Chen, Chia-Hui; Chang, Shu-Fang; Hsiung, Chao Agnes; Kuo, Ken N |
| 國立成功大學 |
2016-05 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong |
| 國立臺灣大學 |
2016 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong; 許駿 |
| 國立臺灣大學 |
2014 |
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
|
Hsu, Chiun; Tsou, Hsiao-Hui; Lin, Shyh-Jer; Wang, Ming-Chung; Yao, Ming; Hwang, Wen-Li; Kao, Woei-Yau; Chiu, Chang-Fang; Lin, Sheng-Fung; Lin, Johnson; Chang, Cheng-Shyong; Tien, Hwei-Fang; Liu, Tsang-Wu; Chen, Pei-Jer; Cheng, Ann-Lii; 姚明; 鄭安理; 許駿; 田蕙芬; 陳培哲 |
| 國立成功大學 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, Kwang-Yu; Tsai, Shan-Yin; Chen, Shang-Hung; Tsou, Hsiao-Hui; Yen, Chia-Jui; Liu, Ko-Jiunn; Fang, Hsun-Lang; Wu, Hung-Chang; Chuang, Bin-Fay; Chou, Shao-Wen; Tang, Careen K.; Liu, Shyun-Yeu; Lu, Pei-Jung; Yen, Ching-Yu; Chang, Jang-Yang |
| 國立成功大學 |
2013-05-20 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, Li-Tzong; Chen, Jen-Shi; Chao, Yee; Tsai, Chang-Sung; Shan, Yan-Shen; Hsu, Chiun; Huang, Shiu-Feng; Tsou, Hsiao-Hui; Lee, Kuan-Der; Chiu, Chang-Fang; Rau, Kun-Ming; Ho, Ching-Liang; Yu, Ming-Sun |
| 國立成功大學 |
2013-04-15 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, Kwang-yu; Tsai, Shan-Yin; Chen, Shang-Hung; Tsou, Hsiao-Hui; Yen, Chia-Jui; Tang, Careen K.; Yen, Ching-Yu; Chang, Jang-Yang |
显示项目 1-10 / 22 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
|
